US Patent Issued to OmniSeq on Nov. 18 for "Methods and systems for determining personalized therapies" (New York, Maryland Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,475,974, issued on Nov. 18, was assigned to OmniSeq Inc. (Buffalo, N.Y.).

"Methods and systems for determining personalized therapies" was invented by Carl Morrison (Fredonia, N.Y.), Sarabjot Pabla (Buffalo, N.Y.), Jeffrey Conroy (Williamsville, N.Y.), Mary Nesline (Buffalo, N.Y.), Mark Gardner (Clarence, N.Y.), Ji He (North Potomac, Md.) and Sean Glenn (East Amherst, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for generating an immune score, the method comprising the steps of: (i) determining a qualitative and/or quantitative assessment of tumor infiltrating lymphocytes in a sample; (ii) determining a qualitative and/or quantitative as...